 |
|
Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
Paperback. Humana Press 2010-10-28.
ISBN 9781617374524
|
|
|
|
Hitta bokens lägsta pris
|
Förlagets beskrivning
A panel of leading academic and pharmaceutical investigators takes stock of the remarkable work that has been accomplished to date with proteasome inhibitors in cancer, and examines emerging therapeutic possibilities. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway. The discussion of rationales for testing proteasome inhibitors in cancer models covers the role of the proteasome in NF-kB activation, the combining of conventional chemotherapy and radiation with proteasome inhibition, notably PS-341, new proteasome methods of inhibiting viral maturation, and the role of protesome inhibition in the treatment of AIDS. The authors also document the development of bortezomib (Velcade?) in Phase I clinical trials and in a multicentered Phase II clinical trials in patients with relapsed and refractory myeloma
Liknande böcker
Recensioner
Den här boken har tyvärr inte några recensioner ännu. Om du redan läst boken, skriv en recension!
Recensera boken
Skriv en recension och dela dina åsikter med andra. Försök att fokusera på bokens innehåll. Läs våra instruktioner för mer information.
Proteasome Inhibitors in Cancer Therapy
Bokrecensioner » Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
|
|
 |
|
|
|
|
